Rare Disease: Patient Centricity

Patient centric rare disease trials begin with a clear understanding of the patient journey, including how individuals are treated and the challenges they face in daily life. Incorporating patient and advocacy group perspectives into study design can reduce participation burden, eliminate unnecessary assessments, and create more practical protocols that support enrollment and retention.